{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:53:11Z","timestamp":1772790791793,"version":"3.50.1"},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021316","name":"AstraZeneca United States","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100021316","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2025.2604971","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T14:57:17Z","timestamp":1766847437000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma"],"prefix":"10.1080","volume":"29","author":[{"given":"George","family":"Dranitsaris","sequence":"first","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]},{"name":"Syracuse University","place":["Syracuse, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Peevyhouse","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Neuhalfen","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee Ann","family":"Dietz","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanh","family":"Huynh","sequence":"additional","affiliation":[{"name":"Cancer Care Associates of York","place":["York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svea K.","family":"Wahlstrom","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Wilmington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha L.","family":"Thompson","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Cambridge, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Teschemaker","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Gaithersburg, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Shetty","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Gaithersburg, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur","family":"Narkhede","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham","place":["Birmingham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ermann","sequence":"additional","affiliation":[{"name":"University of Utah","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Blau","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1270203"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30422-7"},{"key":"e_1_3_7_4_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. National Cancer Institute; 2025 [cited 2025 Feb 23]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/cllsll.html"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.1946"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00595-6"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014960"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.5007"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S377697"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2022.2067526"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018818"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05921-7"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009739"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_7_18_1","volume-title":"Propensity score analysis: statistical methods and applications","author":"Guo S","year":"2011","unstructured":"Guo S, Fraser MW. Propensity score analysis: statistical methods and applications. 2nd ed. Thousand Oaks (CA): Sage Publications; 2011.","edition":"2"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2023.2200167"},{"key":"e_1_3_7_20_1","unstructured":"Cubanski J Neuman T Freed M. Explaining the prescription drug provisions in the Inflation Reduction Act. [cited 2025 Dec 12]. Available from: https:\/\/www.kff.org\/medicare\/explaining-the-prescription-drug-provisions-in-the-inflation-reduction-act\/"},{"key":"e_1_3_7_21_1","unstructured":"Bennette CL Rosen ST Anderson GF. The Inflation Reduction Act. 2025 [cited 2025 Dec 12]. Available from: https:\/\/ascopost.com\/issues\/august-25-2025\/the-inflation-reduction-act-and-ibrutinib\/"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2604971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:52:36Z","timestamp":1772779956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2604971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2604971"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2604971","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}